Foralumab is the first intranasal immune modulator in clinical trials for patients with Multiple System AtrophyBOSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ...
Tiziana Life Sciences reported encouraging brain inflammation findings in its MSA study, strengthening attention on ...
This Saturday at 4:30 p.m., the Mario Alberto Kempes Stadium will host a new chapter of the Córdoba derby, in the Round of 16 ...
In the ashes of Spirit Airlines, which shut down in early May, JetBlue has risen anew. The airline took advantage of the gap ...
BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 ...
Sorana Cîrstea is defying the complications of retiring from tennis at the right moment. Tiziana Fabi / AFP via Getty Images Share article ROME — Tennis retirements are often painful. Whether it was ...
For two decades, John Lam graced the Boston Ballet stage as its principal dancer. Now, he's working with the next generation of dancers to help them achieve their dreams through his non-profit Lam ...
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said on Thursday that preclinical research on its experimental intranasal therapy showed potential to reduce brain inflammation and improve cognitive function ...
Jannik Sinner reached the semi-finals of the Italian Open on Thursday after seeing off Andrey Rublev and establishing a new ...
Roma's derby with Lazio will be played on Sunday afternoon following an agreement between Serie A and authorities in Rome to ...
Two opposite worlds, distant yet united in a single large and complex project. Thus was born “L’Oltre. Dance, Digital and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results